Forodesine Treatment and Post-Transplant Graft-Versus-Host Disease in Two Patients With Acute Leukemia: Facilitation of Graft-Versus-Leukemia Effect?-Reference-Cited by-同舟云学术

Forodesine Treatment and Post-Transplant Graft-Versus-Host Disease in Two Patients With Acute Leukemia: Facilitation of Graft-Versus-Leukemia Effect?

Published:2007-12 Issue: Volume:34 Page:S35-S39
ISSN:0093-7754
Container-title:Seminars in Oncology
language:en
Short-container-title:Seminars in Oncology

Author:

Gore Lia,Stelljes Mattias,Quinones Ralph

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference13 articles.

1. Forodesine IV (BCX-1777) is clinically active in relapsed/refractory T-cell leukemia: Results of a phase II study (interim report);Furman;Blood,2006

2. Intravenous forodesine (BCX-1777), a novel purine nucleoside phosphorylase (PNP) inhibitor, demonstrates clinical activity in phase I/II studies in patients with B-cell acute lymphoblastic leukemia;Furman;Blood,2004

3. Forodesine (Fodosine™), a PNP inhibitor active in relapsed or refractory T-cell leukemia patients (phase II study);Furman;Blood,2005

4. Outcome for adolescent and young adults 16-21 years of age (AYA) with ALL treated on the Children’s Cancer Group (CCG) 1961 study;Nachman;Blood,2004

5. Purine nucleoside phosphorylase inhibitors in T-cell malignancies;Bantia;Curr Opin Drug Discov Devel,2004

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment duration with immune-based therapies in Cancer: an enigma;Journal for ImmunoTherapy of Cancer;2018-12

2. Enzymatic Transition States and Drug Design;Chemical Reviews;2018-10-18

3. Forodesine in the treatment of cutaneous T-cell lymphoma;Expert Opinion on Investigational Drugs;2017-05-05

4. Older and new purine nucleoside analogs for patients with acute leukemias;Cancer Treatment Reviews;2013-12

5. Nucleoside Analogs in the Therapy of T-Cell Malignancies;T-Cell Lymphomas;2012-09-23